Determination of the 90% Effective Dose of Dexmedetomidine for ...

Findings: A total of 29 patients were recruited, of whom 14 patients (48.3%) underwent successful treatment. The ED90 of dexmedetomidine ...

Determination of the ED90 of Dexmedetomidine Infusion to Prevent ...

However, a wide dose range is used for preventing EA, and the optimal dose remains unknown. This study was aimed at determining the optimal dose (the 90% ...

In conclusion, under the conditions of the present study, the ED90 of dexmedetomidine for the successful treatment of severe postoperative CRBD ...

Determination of the 90% Effective Dose of Dexmedetomidine for ...

The ED90 of dexmedetomidine for the successful treatment of severe postoperative CRBD during recovery is 0.55 mcg/kg.

Determination of the 90% Effective Dose of Dexmedetomidine for ...

Determination of the 90% Effective Dose of Dexmedetomidine for. Treating Postoperative Catheter‑related Bladder Discomfort During. Recovery: An Open-label ...

Determination of the effective dose of dexmedetomidine to achieve ...

Determination of the effective dose of dexmedetomidine to achieve loss of consciousness during anesthesia induction · Background: Dexmedetomidine (DEX) is a ...

Determining the Optimal Dosage of Dexmedetomidine for Smooth ...

Consequently, this study evaluated 44 patients aged 65 years and older under- going general anesthesia for spinal surgery to determine the. 90% effective dose ( ...

The 90% effective dose of intranasal dexmedetomidine for ...

The 90% effective dose of intranasal dexmedetomidine for sedation in children with CHD was 2.13 μg/kg before cardiac surgery and 3.51 μg/kg after cardiac ...

Determination of the 90% effective dose of intranasal ...

The 90% effective dose of intranasal DEX sedation for EEG was 3.28 μg kg−1in children under 3 years old. CONFLICT OF INTEREST. All authors ...

"Determining the Optimal Dosage of Dexmedetomidine for Smooth ...

This study aimed to evaluate patients aged 65 years and older undergoing general anesthesia to determine the 90% effective dose (ED90) of ...

The 95% effective dose of dexmedetomidine to induce adequate ...

The 95% effective dose of dexmedetomidine to induce adequate sedation in patients with chronic insomnia disorder was 1.75 μg/kg.

Effective dose of dexmedetomidine to induce adequate sedation

In the current study, an appropriate dose of dexmedetomidine for the sedation of elderly patients under spinal anesthesia was determined. The ED ...

Determining the Optimal Dosage of Dexmedetomidine for Smooth ...

This study aimed to evaluate patients aged 65 years and older undergoing general anesthesia to determine the 90% effective dose (ED90) of ...

Dexmedetomidine and Propofol Sedation in Critically Ill Patients and ...

We used double stratification analysis to produce quartiles of steady infusion rates of dexmedetomidine while escalating propofol dose and vice ...

Determination of the ED90 of Dexmedetomidine Infusion to Prevent ...

Determination of the ED90 of Dexmedetomidine Infusion to Prevent Emergence Agitation in Children Undergoing Dental Rehabilitation With Sevoflurane ...

The 90% effective dose (ED90) of remimazolam for inhibiting ...

After the anestheisa induction, the sedation was maintained by continuous infusion of 0.2 to 1 mg/kg/h of remimazolam and 0 to 1 µg/kg/min of ...

(PDF) Determination of the effective dose of dexmedetomidine to ...

The ED50 and ED95 of the initial infusion rate of DEX were 0.115 and 0.200 μg/kg/min, respectively, and the mean induction time was 18.3 min.

Determination of the 90% Effective Dose of Dexmedetomidine for ...

Determination of the 90% Effective Dose of Dexmedetomidine for Treating Postoperative Catheter‑related Bladder Discomfort During Recovery: An Open-label, ...

Determination of the ED 95 of a single bolus dose of ... - Europe PMC

The ED 95 of dexmedetomidine for adequate sedation in children with obesity was 0.75 μg kg -1 with 95% CI of 0.638-0.780 μg kg -1.

Age-Specific Dose Regimens of Dexmedetomidine for Pediatric

Dexmedetomidine is already approved for clinical use in adults for intensive care patients and surgical/procedural sedation globally; thus, the efficacy and ...